뉴스/Reuters/Sino Biopharmaceutical Says TQB2102 Included In Breakthrough Therapeutic Designation Process In ChinaSino Biopharmaceutical Says TQB2102 Included In Breakthrough Therapeutic Designation Process In ChinaRefinitiv1분 미만 읽기1177Sino Biopharmaceutical Ltd 1177:TQB2102 INCLUDED IN BREAKTHROUGH THERAPEUTIC DESIGNATION PROCESS IN CHINAReuters아시아중국 주식홍콩 주식© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html더 보기이 뉴스를 읽으려면 로그인하거나 평생 무료 계정을 만드십시오렛츠고
